Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes (2001)
The incidence of drug-induced proarrhythmias in the general population is largely unknown. Knowledge regarding incidence and risk factors is mainly derived from studies during clinical development of...
Frick, M., Darpö, B., Östergren, J., Rosenqvist, M.
Aims To determine whether magnesium given orally decreases the recurrence rate of atrial fibrillation after elective direct current cardioversion of persistent atrial fibrillation. Methods and...
Houltz, B., Darpö, B., Swedberg, K., Blomström, P., Jensen, S.M., ...
Aims Drug-induced increase in QT dispersion has been associated with increased risk of ventricular proarrhythmia. The aim of the present study was to compare QT dispersion during atrial fibrillation...
Nanthakumar, K., Bergfeldt, L., Darpö, B.
Aims Measurement of the refractory properties of asymptomatic overt accessory pathways is performed to assess the risk for significant arrhythmias. We hypothesized that a transoesophageal atrial...
Gadler, F., Linde, C., Darpö, B.
Aims Atrioventricular synchronous pacing offers symptomatic relief for patients with drug-refractory hypertrophic obstructive cardiomyopathy. Successful treatment requires complete right ventricular...
Edner, M., Caidahl, K., Bergfeldt, L., Darpö, B., Edvardsson, N., Rosenqvist, M.
BACKGROUND--In patients with drug resistant incessant supraventricular tachycardia, radiofrequency induced ablation of the atrioventricular junction and pacemaker implantation have hitherto been...